Q3 2023 · 13F-HR
SECTOR GAMMA ASholdings as filed
Filed 2023-11-06 · accession 0000945621-23-000545
$391.3M
Reported value
28
Positions
2023-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 375558103 | GILD | GILEAD SCIENCES INC | $46.7M | 11.9% | 623,123 | Common | SOLE |
| 110122108 | BMY | BRISTOL-MYERS SQUIBB CO | $39.0M | 9.96% | 671,780 | Common | SOLE |
| 09062X103 | BIIB | BIOGEN INC | $26.8M | 6.85% | 104,286 | Common | SOLE |
| G5960L103 | MDT | MEDTRONIC PLC | $25.7M | 6.57% | 327,903 | Common | SOLE |
| 45337C102 | INCY | INCYTE CORP | $25.0M | 6.39% | 432,545 | Common | SOLE |
| 14149Y108 | CAH | CARDINAL HEALTH INC | $22.9M | 5.86% | 264,136 | Common | SOLE |
| 075887109 | BDX | BECTON DICKINSON & CO | $18.6M | 4.75% | 71,884 | Common | SOLE |
| 036752103 | ELV | ELEVANCE HEALTH INC | $17.9M | 4.58% | 41,147 | Common | SOLE |
| 98956P102 | ZBH | ZIMMER BIOMET HOLDINGS INC | $17.9M | 4.56% | 159,069 | Common | SOLE |
| 36266G107 | GEHC | GE HEALTHCARE TECHNOLOGIES I | $15.6M | 3.99% | 229,589 | Common | SOLE |
| 15135B101 | CNC | CENTENE CORP DEL | $15.4M | 3.93% | 223,148 | Common | SOLE |
| 28176E108 | EW | EDWARDS LIFESCIENCES CORP | $14.8M | 3.77% | 212,995 | Common | SOLE |
| 50540R409 | LSI | LABORATORY CORP AMER HLDGS | $13.0M | 3.33% | 64,857 | Common | SOLE |
| 379577208 | GMED | GLOBUS MED INC | $11.0M | 2.81% | 221,827 | Common | SOLE |
| 88033G407 | THC | TENET HEALTHCARE CORP | $10.4M | 2.66% | 157,975 | Common | SOLE |
| 148806102 | CTLTEUR | CATALENT INC | $9.4M | 2.41% | 207,129 | Common | SOLE |
| 02043Q107 | ALNY | ALNYLAM PHARMACEUTICALS INC | $9.4M | 2.40% | 52,968 | Common | SOLE |
| 09061G101 | BMRN | BIOMARIN PHARMACEUTICAL INC | $8.5M | 2.17% | 96,048 | Common | SOLE |
| 462222100 | IONS | IONIS PHARMACEUTICALS INC | $7.5M | 1.92% | 165,616 | Common | SOLE |
| 071813109 | BAX | BAXTER INTL INC | $7.3M | 1.86% | 193,243 | Common | SOLE |
| 116794108 | BRKR | BRUKER CORP | $6.4M | 1.65% | 103,355 | Common | SOLE |
| 90400D108 | RARE | ULTRAGENYX PHARMACEUTICAL IN | $4.1M | 1.05% | 115,166 | Common | SOLE |
| N72482123 | — | QIAGEN NV | $4.1M | 1.04% | 100,713 | Common | SOLE |
| 004225108 | ACAD | ACADIA PHARMACEUTICALS INC | $3.7M | 0.96% | 179,785 | Common | SOLE |
| 516544103 | LNTH | LANTHEUS HLDGS INC | $3.5M | 0.90% | 50,962 | Common | SOLE |
| 49177J102 | KVUE | KENVUE INC | $2.9M | 0.74% | 144,017 | Common | SOLE |
| 023436108 | AMED | AMEDISYS INC | $2.3M | 0.59% | 24,585 | Common | SOLE |
| 92764N102 | VIR | VIR BIOTECHNOLOGY INC | $1.4M | 0.36% | 148,538 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.